Nine Chapters Capital Management’s Novavax NVAX Stock Holding History

Nine Chapters Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13,670	Closed	-$1.93M	–	370
2015 Q3	$1.93M	Buy	+13,670	New	+$3.07M	0.17%	168
2014 Q4	–	Sell	-3,970	Closed	-$331K	–	1091
2014 Q3	$331K	Buy	+3,970	New	+$359K	0.03%	673
2014 Q2	–	Sell	-930	Closed	-$84K	–	1071
2014 Q1	$84K	Buy	+930	New	+$104K	0.01%	769

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nine Chapters Capital Management's NVAX Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Novavax (NVAX) in Q4 2015, closing a stake of 13,670 shares — an estimated $1.93M sold.

Nine Chapters Capital Management first reported a position in NVAX in Q1 2014 and held it in 3 quarters. The position peaked at $1.93M in Q3 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

Nine Chapters Capital Management reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 13,670 Novavax shares in Q4 2015, an estimated $1.93M.
Nine Chapters Capital Management first reported a position in Novavax in Q1 2014 and held it in 3 quarters.
Nine Chapters Capital Management's Novavax position peaked at $1.93M in Q3 2015.
173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.